MedTrace Logo

LocalVancomycinPowderToPreventPeriprostheticJointInfection.

NCT05697965 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2023-02-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and complication profile of local vancomycin application in primary arthroplasty. The investigators hypothesized that the use of local antibiotics would decrease the rate of infection compared to controls and this will be achieved by applying 1 gm of vancomycin powder intracapsularly.

Conditions

  • Arthroplasty Complications
  • Periprosthetic Fracture of Hip

Interventions

DRUG

Vancomycin

applying 1 gm of vancomycin powder intracapsularly during primary total knee and hip arthroplasty to prevent periprosthetic joint infection

PROCEDURE

Total knee or total hip arthroplasty

Primary total knee or total hip arthroplasty without using local vancomycin

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Yossef Saleh · Vice president

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-05-31
Completion
2024-08-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05697965 on ClinicalTrials.gov